NSD2 and cancer: In several cancer cell lines with elevated NSD2 expression, NSD2 knockdown inhibits the WNT/β-catenin/TCF-4 pathway and its downstream cyclin D1 expression through reduced H3K36me3, leading to impaired cell cycle progression [112].